

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.79372758 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.44670206 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.44670206 |
| 4 | alpha-linolenic acid metabolic process (GO:0036109) | 5.40869690 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.16709459 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.16709459 |
| 7 | negative regulation of protein activation cascade (GO:2000258) | 4.93323874 |
| 8 | negative regulation of complement activation (GO:0045916) | 4.74226992 |
| 9 | complement activation, classical pathway (GO:0006958) | 4.73797587 |
| 10 | complement activation (GO:0006956) | 4.62292717 |
| 11 | high-density lipoprotein particle remodeling (GO:0034375) | 4.61215351 |
| 12 | reverse cholesterol transport (GO:0043691) | 4.50844146 |
| 13 | regulation of cholesterol esterification (GO:0010872) | 4.47517382 |
| 14 | protein activation cascade (GO:0072376) | 4.46542580 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 4.39349952 |
| 16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.31790015 |
| 17 | protein carboxylation (GO:0018214) | 4.31790015 |
| 18 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.28864812 |
| 19 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.22334300 |
| 20 | plasma lipoprotein particle remodeling (GO:0034369) | 4.19854993 |
| 21 | protein-lipid complex remodeling (GO:0034368) | 4.19854993 |
| 22 | macromolecular complex remodeling (GO:0034367) | 4.19854993 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 4.14016213 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 4.11671413 |
| 25 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.10914589 |
| 26 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.10914589 |
| 27 | drug catabolic process (GO:0042737) | 4.10640015 |
| 28 | complement activation, alternative pathway (GO:0006957) | 4.08259313 |
| 29 | low-density lipoprotein particle remodeling (GO:0034374) | 4.01248212 |
| 30 | regulation of protein activation cascade (GO:2000257) | 3.99074380 |
| 31 | regulation of triglyceride catabolic process (GO:0010896) | 3.94969418 |
| 32 | regulation of fibrinolysis (GO:0051917) | 3.90868377 |
| 33 | epoxygenase P450 pathway (GO:0019373) | 3.85811631 |
| 34 | omega-hydroxylase P450 pathway (GO:0097267) | 3.83268580 |
| 35 | blood coagulation, intrinsic pathway (GO:0007597) | 3.82602784 |
| 36 | phospholipid efflux (GO:0033700) | 3.81790206 |
| 37 | regulation of complement activation (GO:0030449) | 3.81257494 |
| 38 | urea cycle (GO:0000050) | 3.76213711 |
| 39 | urea metabolic process (GO:0019627) | 3.76213711 |
| 40 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.72388284 |
| 41 | bile acid biosynthetic process (GO:0006699) | 3.70628540 |
| 42 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.69287030 |
| 43 | negative regulation of blood coagulation (GO:0030195) | 3.69146679 |
| 44 | negative regulation of hemostasis (GO:1900047) | 3.69146679 |
| 45 | negative regulation of humoral immune response (GO:0002921) | 3.68681991 |
| 46 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.67592321 |
| 47 | exogenous drug catabolic process (GO:0042738) | 3.66450079 |
| 48 | regulation of cholesterol homeostasis (GO:2000188) | 3.65530546 |
| 49 | regulation of humoral immune response (GO:0002920) | 3.63986572 |
| 50 | plasma lipoprotein particle assembly (GO:0034377) | 3.61914355 |
| 51 | acute-phase response (GO:0006953) | 3.55526071 |
| 52 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.55359167 |
| 53 | cysteine metabolic process (GO:0006534) | 3.53884653 |
| 54 | indolalkylamine catabolic process (GO:0046218) | 3.53809346 |
| 55 | tryptophan catabolic process (GO:0006569) | 3.53809346 |
| 56 | indole-containing compound catabolic process (GO:0042436) | 3.53809346 |
| 57 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.52858169 |
| 58 | glyoxylate metabolic process (GO:0046487) | 3.52126165 |
| 59 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.51626628 |
| 60 | kynurenine metabolic process (GO:0070189) | 3.51339877 |
| 61 | cellular modified amino acid catabolic process (GO:0042219) | 3.49286516 |
| 62 | negative regulation of sterol transport (GO:0032372) | 3.47523607 |
| 63 | negative regulation of cholesterol transport (GO:0032375) | 3.47523607 |
| 64 | Golgi transport vesicle coating (GO:0048200) | 3.46784093 |
| 65 | COPI coating of Golgi vesicle (GO:0048205) | 3.46784093 |
| 66 | linoleic acid metabolic process (GO:0043651) | 3.46165299 |
| 67 | plasma lipoprotein particle organization (GO:0071827) | 3.44740123 |
| 68 | plasma lipoprotein particle clearance (GO:0034381) | 3.43722074 |
| 69 | triglyceride homeostasis (GO:0070328) | 3.42142601 |
| 70 | acylglycerol homeostasis (GO:0055090) | 3.42142601 |
| 71 | negative regulation of coagulation (GO:0050819) | 3.42057579 |
| 72 | opsonization (GO:0008228) | 3.41310650 |
| 73 | tryptophan metabolic process (GO:0006568) | 3.41270953 |
| 74 | nitrogen cycle metabolic process (GO:0071941) | 3.40497776 |
| 75 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.36478857 |
| 76 | amino-acid betaine metabolic process (GO:0006577) | 3.35010478 |
| 77 | homocysteine metabolic process (GO:0050667) | 3.30896084 |
| 78 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.29669939 |
| 79 | regulation of triglyceride metabolic process (GO:0090207) | 3.28245265 |
| 80 | tyrosine metabolic process (GO:0006570) | 3.28077719 |
| 81 | protein-lipid complex assembly (GO:0065005) | 3.27461827 |
| 82 | lipoprotein metabolic process (GO:0042157) | 3.27406964 |
| 83 | detection of molecule of bacterial origin (GO:0032490) | 3.26543368 |
| 84 | protein-lipid complex subunit organization (GO:0071825) | 3.25843444 |
| 85 | cholesterol efflux (GO:0033344) | 3.25723359 |
| 86 | negative regulation of wound healing (GO:0061045) | 3.25570412 |
| 87 | COPII vesicle coating (GO:0048208) | 3.25327424 |
| 88 | alanine transport (GO:0032328) | 3.24299973 |
| 89 | serine family amino acid catabolic process (GO:0009071) | 3.21649883 |
| 90 | negative regulation of type 2 immune response (GO:0002829) | 3.21466469 |
| 91 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.21173139 |
| 92 | bile acid metabolic process (GO:0008206) | 3.21163150 |
| 93 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.18720075 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 3.16867097 |
| 95 | glutamate metabolic process (GO:0006536) | 3.15858318 |
| 96 | regulation of plasminogen activation (GO:0010755) | 3.14355619 |
| 97 | cellular ketone body metabolic process (GO:0046950) | 3.14276969 |
| 98 | positive regulation of fatty acid oxidation (GO:0046321) | 3.13602500 |
| 99 | lysine metabolic process (GO:0006553) | 3.12947478 |
| 100 | lysine catabolic process (GO:0006554) | 3.12947478 |
| 101 | regulation of cholesterol metabolic process (GO:0090181) | 3.12751718 |
| 102 | alpha-amino acid catabolic process (GO:1901606) | 3.08724745 |
| 103 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.07490889 |
| 104 | aromatic amino acid family metabolic process (GO:0009072) | 3.06922844 |
| 105 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.06830574 |
| 106 | intestinal cholesterol absorption (GO:0030299) | 3.04527025 |
| 107 | coenzyme catabolic process (GO:0009109) | 3.04500740 |
| 108 | regulation of apoptotic cell clearance (GO:2000425) | 3.03386245 |
| 109 | fibrinolysis (GO:0042730) | 3.01120710 |
| 110 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.00138123 |
| 111 | short-chain fatty acid metabolic process (GO:0046459) | 2.99448776 |
| 112 | cellular amino acid catabolic process (GO:0009063) | 2.95979685 |
| 113 | ethanol oxidation (GO:0006069) | 2.95151112 |
| 114 | cAMP biosynthetic process (GO:0006171) | 2.94618922 |
| 115 | thioester biosynthetic process (GO:0035384) | 2.93710759 |
| 116 | acyl-CoA biosynthetic process (GO:0071616) | 2.93710759 |
| 117 | positive regulation of blood coagulation (GO:0030194) | 2.93646286 |
| 118 | positive regulation of hemostasis (GO:1900048) | 2.93646286 |
| 119 | phospholipid homeostasis (GO:0055091) | 2.93575479 |
| 120 | hyaluronan catabolic process (GO:0030214) | 2.93384627 |
| 121 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.93101375 |
| 122 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.93101375 |
| 123 | drug transmembrane transport (GO:0006855) | 2.92162682 |
| 124 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.91647467 |
| 125 | positive regulation of steroid metabolic process (GO:0045940) | 2.90219022 |
| 126 | regulation of acute inflammatory response (GO:0002673) | 2.89659693 |
| 127 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.86932948 |
| 128 | acute inflammatory response (GO:0002526) | 2.85722418 |
| 129 | cellular glucuronidation (GO:0052695) | 2.85284466 |
| 130 | acetyl-CoA metabolic process (GO:0006084) | 2.85236231 |
| 131 | positive regulation of coagulation (GO:0050820) | 2.85123850 |
| 132 | negative regulation of platelet activation (GO:0010544) | 2.83729948 |
| 133 | 4-hydroxyproline metabolic process (GO:0019471) | 2.83579705 |
| 134 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.82664270 |
| 135 | negative regulation of lipase activity (GO:0060192) | 2.79834969 |
| 136 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.73878743 |
| 137 | hyaluronan metabolic process (GO:0030212) | 2.69499418 |
| 138 | drug metabolic process (GO:0017144) | 2.60929733 |
| 139 | positive regulation of protein sumoylation (GO:0033235) | 2.57662633 |
| 140 | regulation of macrophage chemotaxis (GO:0010758) | 2.53886592 |
| 141 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.50918775 |
| 142 | drug transport (GO:0015893) | 2.50387325 |
| 143 | positive regulation of cholesterol efflux (GO:0010875) | 2.47737841 |
| 144 | protein K11-linked deubiquitination (GO:0035871) | 2.47115117 |
| 145 | surfactant homeostasis (GO:0043129) | 2.45480930 |
| 146 | regulation of blood coagulation (GO:0030193) | 2.44014527 |
| 147 | regulation of hemostasis (GO:1900046) | 2.44014527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.33702077 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.83881866 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.95334078 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.77215315 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.90889847 |
| 6 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.88950985 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.67553161 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.15045887 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.03118301 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.00908140 |
| 11 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.41275375 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.29925635 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.18598808 |
| 14 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.14431284 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.06864423 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.95928272 |
| 17 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.95426014 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.94073328 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.88391536 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87024952 |
| 21 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.80946423 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.78569942 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.76780145 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.57369083 |
| 25 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.52624235 |
| 26 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.52093390 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.50331935 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.47782211 |
| 29 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.46249835 |
| 30 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.45514907 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.44706929 |
| 32 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35825614 |
| 33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.32906061 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31899655 |
| 35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26499215 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26418291 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24657388 |
| 38 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.24309699 |
| 39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23810502 |
| 40 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23322967 |
| 41 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20966541 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.18950179 |
| 43 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15588882 |
| 44 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.15518353 |
| 45 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.15518353 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.15495759 |
| 47 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.15332761 |
| 48 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13226910 |
| 49 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.11758258 |
| 50 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.11670998 |
| 51 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10774350 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06955880 |
| 53 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06404831 |
| 54 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.04488961 |
| 55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04134658 |
| 56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03716253 |
| 57 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03429408 |
| 58 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02230399 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01619971 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00995064 |
| 61 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.00643492 |
| 62 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99762428 |
| 63 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99620320 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99249291 |
| 65 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99123151 |
| 66 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98163443 |
| 67 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96831026 |
| 68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96495370 |
| 69 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96345197 |
| 70 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95490418 |
| 71 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95490418 |
| 72 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95005032 |
| 73 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95005032 |
| 74 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94798973 |
| 75 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.94191537 |
| 76 | GATA1_22025678_ChIP-Seq_K562_Human | 0.93930605 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.93040693 |
| 78 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.92393418 |
| 79 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.92281085 |
| 80 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91915885 |
| 81 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90561390 |
| 82 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90520849 |
| 83 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90262217 |
| 84 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90203490 |
| 85 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.89686649 |
| 86 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.89686649 |
| 87 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.89686649 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89482952 |
| 89 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.88460878 |
| 90 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.88140169 |
| 91 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.87988919 |
| 92 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.87411838 |
| 93 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86337343 |
| 94 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85112297 |
| 95 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84225436 |
| 96 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.84039559 |
| 97 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.83882697 |
| 98 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.83598938 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.82865405 |
| 100 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.82070566 |
| 101 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.81845555 |
| 102 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.81801624 |
| 103 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.81443239 |
| 104 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.80744732 |
| 105 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.80304433 |
| 106 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.80297500 |
| 107 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79973993 |
| 108 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.79600075 |
| 109 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.78856082 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78704083 |
| 111 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.78255350 |
| 112 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.77917913 |
| 113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.77689016 |
| 114 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.77355570 |
| 115 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76852296 |
| 116 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.75026028 |
| 117 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74586324 |
| 118 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.73373600 |
| 119 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.72666252 |
| 120 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72580266 |
| 121 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72476658 |
| 122 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.70085317 |
| 123 | RXR_22108803_ChIP-Seq_LS180_Human | 0.68743482 |
| 124 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.68228947 |
| 125 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.66880836 |
| 126 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.65707404 |
| 127 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.64463757 |
| 128 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.63941100 |
| 129 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.63819350 |
| 130 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.63725069 |
| 131 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.63170157 |
| 132 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.63041508 |
| 133 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.62926148 |
| 134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.62171237 |
| 135 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61364574 |
| 136 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.61305838 |
| 137 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.61044707 |
| 138 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.60953047 |
| 139 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.60909982 |
| 140 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.59342412 |
| 141 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.59060232 |
| 142 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58645093 |
| 143 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.57741262 |
| 144 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.57330769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.03038729 |
| 2 | MP0005360_urolithiasis | 5.48800572 |
| 3 | MP0005365_abnormal_bile_salt | 4.85764407 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.20128752 |
| 5 | MP0009840_abnormal_foam_cell | 3.30023881 |
| 6 | MP0003195_calcinosis | 3.13556135 |
| 7 | MP0006054_spinal_hemorrhage | 3.10620511 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 3.03933403 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.02026988 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.98187677 |
| 11 | MP0003252_abnormal_bile_duct | 2.95010442 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.78342497 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.65624316 |
| 14 | MP0005332_abnormal_amino_acid | 2.49913430 |
| 15 | MP0001881_abnormal_mammary_gland | 2.37664811 |
| 16 | MP0005083_abnormal_biliary_tract | 2.35750424 |
| 17 | MP0009384_cardiac_valve_regurgitation | 2.34139834 |
| 18 | MP0008004_abnormal_stomach_pH | 2.33382010 |
| 19 | MP0002254_reproductive_system_inflammat | 2.27529821 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.10772078 |
| 21 | MP0008961_abnormal_basal_metabolism | 2.06514773 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 2.03359333 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.02503250 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.91534527 |
| 25 | MP0003303_peritoneal_inflammation | 1.91478326 |
| 26 | MP0003279_aneurysm | 1.87483067 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 1.84716394 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.80995780 |
| 29 | MP0003011_delayed_dark_adaptation | 1.80894807 |
| 30 | MP0005275_abnormal_skin_tensile | 1.78837152 |
| 31 | MP0000609_abnormal_liver_physiology | 1.69201586 |
| 32 | MP0003690_abnormal_glial_cell | 1.56989369 |
| 33 | MP0005503_abnormal_tendon_morphology | 1.55272037 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.53332029 |
| 35 | MP0005670_abnormal_white_adipose | 1.48593370 |
| 36 | MP0006082_CNS_inflammation | 1.43856948 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.42318622 |
| 38 | MP0002998_abnormal_bone_remodeling | 1.41464551 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.38763004 |
| 40 | MP0005220_abnormal_exocrine_pancreas | 1.36113285 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.32222052 |
| 42 | MP0004883_abnormal_blood_vessel | 1.29927375 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.27870731 |
| 44 | MP0009785_altered_susceptibility_to | 1.27249901 |
| 45 | MP0005319_abnormal_enzyme/_coenzyme | 1.26586607 |
| 46 | MP0003868_abnormal_feces_composition | 1.25381457 |
| 47 | MP0001915_intracranial_hemorrhage | 1.25262365 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.23747041 |
| 49 | MP0004272_abnormal_basement_membrane | 1.22972939 |
| 50 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.22372359 |
| 51 | MP0002419_abnormal_innate_immunity | 1.21573235 |
| 52 | MP0002933_joint_inflammation | 1.19778412 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 1.17809864 |
| 54 | MP0003436_decreased_susceptibility_to | 1.17392291 |
| 55 | MP0001790_abnormal_immune_system | 1.16654336 |
| 56 | MP0005387_immune_system_phenotype | 1.16654336 |
| 57 | MP0008469_abnormal_protein_level | 1.16350673 |
| 58 | MP0003329_amyloid_beta_deposits | 1.15352877 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 1.13457120 |
| 60 | MP0002168_other_aberrant_phenotype | 1.11774928 |
| 61 | MP0000604_amyloidosis | 1.11033214 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.09616247 |
| 63 | MP0004510_myositis | 1.08060503 |
| 64 | MP0000767_abnormal_smooth_muscle | 1.07339426 |
| 65 | MP0004130_abnormal_muscle_cell | 1.06724109 |
| 66 | MP0001542_abnormal_bone_strength | 1.06326877 |
| 67 | MP0010368_abnormal_lymphatic_system | 1.05005394 |
| 68 | MP0005379_endocrine/exocrine_gland_phen | 1.04055026 |
| 69 | MP0001944_abnormal_pancreas_morphology | 1.02965371 |
| 70 | MP0005636_abnormal_mineral_homeostasis | 1.02405158 |
| 71 | MP0002148_abnormal_hypersensitivity_rea | 1.02340564 |
| 72 | MP0003091_abnormal_cell_migration | 0.98665470 |
| 73 | MP0000343_altered_response_to | 0.96926732 |
| 74 | MP0003183_abnormal_peptide_metabolism | 0.96300633 |
| 75 | MP0000639_abnormal_adrenal_gland | 0.94320831 |
| 76 | MP0000249_abnormal_blood_vessel | 0.94163835 |
| 77 | MP0004043_abnormal_pH_regulation | 0.94027202 |
| 78 | MP0005451_abnormal_body_composition | 0.93364393 |
| 79 | MP0003045_fibrosis | 0.92055691 |
| 80 | MP0002971_abnormal_brown_adipose | 0.90857363 |
| 81 | MP0002295_abnormal_pulmonary_circulatio | 0.88377830 |
| 82 | MP0005025_abnormal_response_to | 0.86860601 |
| 83 | MP0002060_abnormal_skin_morphology | 0.86066275 |
| 84 | MP0001756_abnormal_urination | 0.86000751 |
| 85 | MP0001851_eye_inflammation | 0.84969493 |
| 86 | MP0005390_skeleton_phenotype | 0.84597589 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 0.81943206 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.81765313 |
| 89 | MP0001835_abnormal_antigen_presentation | 0.81594777 |
| 90 | MP0003075_altered_response_to | 0.81074704 |
| 91 | MP0002693_abnormal_pancreas_physiology | 0.80946776 |
| 92 | MP0000003_abnormal_adipose_tissue | 0.80937194 |
| 93 | MP0001764_abnormal_homeostasis | 0.80234456 |
| 94 | MP0001958_emphysema | 0.80053069 |
| 95 | MP0003724_increased_susceptibility_to | 0.79808413 |
| 96 | MP0001661_extended_life_span | 0.77609111 |
| 97 | MP0002108_abnormal_muscle_morphology | 0.77213573 |
| 98 | MP0002896_abnormal_bone_mineralization | 0.76423904 |
| 99 | MP0004133_heterotaxia | 0.76376261 |
| 100 | MP0001845_abnormal_inflammatory_respons | 0.76374332 |
| 101 | MP0005334_abnormal_fat_pad | 0.75745832 |
| 102 | MP0009642_abnormal_blood_homeostasis | 0.75595663 |
| 103 | MP0000598_abnormal_liver_morphology | 0.74351976 |
| 104 | MP0002405_respiratory_system_inflammati | 0.74118766 |
| 105 | MP0005023_abnormal_wound_healing | 0.74101857 |
| 106 | MP0000920_abnormal_myelination | 0.73250318 |
| 107 | MP0004782_abnormal_surfactant_physiolog | 0.73157141 |
| 108 | MP0009764_decreased_sensitivity_to | 0.73040592 |
| 109 | MP0001243_abnormal_dermal_layer | 0.72912964 |
| 110 | MP0003186_abnormal_redox_activity | 0.70419679 |
| 111 | MP0002876_abnormal_thyroid_physiology | 0.70254092 |
| 112 | MP0005508_abnormal_skeleton_morphology | 0.70152980 |
| 113 | MP0002128_abnormal_blood_circulation | 0.69614760 |
| 114 | MP0005647_abnormal_sex_gland | 0.69185083 |
| 115 | MP0005257_abnormal_intraocular_pressure | 0.68613225 |
| 116 | MP0005375_adipose_tissue_phenotype | 0.68004737 |
| 117 | MP0000685_abnormal_immune_system | 0.67817154 |
| 118 | MP0005058_abnormal_lysosome_morphology | 0.67227878 |
| 119 | MP0005388_respiratory_system_phenotype | 0.67053437 |
| 120 | MP0002133_abnormal_respiratory_system | 0.67053437 |
| 121 | MP0003950_abnormal_plasma_membrane | 0.66904350 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.66766003 |
| 123 | MP0005376_homeostasis/metabolism_phenot | 0.66630257 |
| 124 | MP0003953_abnormal_hormone_level | 0.66574509 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.66353391 |
| 126 | MP0005395_other_phenotype | 0.66319190 |
| 127 | MP0001765_abnormal_ion_homeostasis | 0.65665092 |
| 128 | MP0009763_increased_sensitivity_to | 0.64459301 |
| 129 | MP0000678_abnormal_parathyroid_gland | 0.64002348 |
| 130 | MP0005535_abnormal_body_temperature | 0.63939185 |
| 131 | MP0005166_decreased_susceptibility_to | 0.63661836 |
| 132 | MP0005448_abnormal_energy_balance | 0.62684167 |
| 133 | MP0003638_abnormal_response/metabolism_ | 0.62347809 |
| 134 | MP0005595_abnormal_vascular_smooth | 0.61694064 |
| 135 | MP0001986_abnormal_taste_sensitivity | 0.60514509 |
| 136 | MP0004264_abnormal_extraembryonic_tissu | 0.59685986 |
| 137 | MP0005646_abnormal_pituitary_gland | 0.59232168 |
| 138 | MP0004858_abnormal_nervous_system | 0.57692843 |
| 139 | MP0003656_abnormal_erythrocyte_physiolo | 0.56357206 |
| 140 | MP0003566_abnormal_cell_adhesion | 0.56042091 |
| 141 | MP0000230_abnormal_systemic_arterial | 0.54926135 |
| 142 | MP0005408_hypopigmentation | 0.54601608 |
| 143 | MP0002928_abnormal_bile_duct | 0.52994199 |
| 144 | MP0000163_abnormal_cartilage_morphology | 0.51950252 |
| 145 | MP0004885_abnormal_endolymph | 0.51546828 |
| 146 | MP0001502_abnormal_circadian_rhythm | 0.50458578 |
| 147 | MP0005164_abnormal_response_to | 0.49622755 |
| 148 | MP0005165_increased_susceptibility_to | 0.49572506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.46116807 |
| 2 | Xanthomatosis (HP:0000991) | 5.41872244 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.31487141 |
| 4 | Hypoglycemic coma (HP:0001325) | 5.01976681 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.84763233 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 4.83102676 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.49706954 |
| 8 | Hypoglycemic seizures (HP:0002173) | 4.48017210 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.42093503 |
| 10 | Hypoalphalipoproteinemia (HP:0003233) | 4.24339611 |
| 11 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.11409622 |
| 12 | Complement deficiency (HP:0004431) | 4.05639603 |
| 13 | Ketoacidosis (HP:0001993) | 4.03127024 |
| 14 | Ketosis (HP:0001946) | 3.92282270 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.77503183 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.75930906 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 3.62482138 |
| 18 | Symptomatic seizures (HP:0011145) | 3.62292857 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.59454910 |
| 20 | Hyperglycinuria (HP:0003108) | 3.33333810 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.29562304 |
| 22 | Abnormality of the intrinsic pathway (HP:0010989) | 3.28729033 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.15889519 |
| 24 | Hyperglycinemia (HP:0002154) | 3.15301586 |
| 25 | Hyperammonemia (HP:0001987) | 3.12773321 |
| 26 | Back pain (HP:0003418) | 3.12297785 |
| 27 | Late onset (HP:0003584) | 3.11678843 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.11078788 |
| 29 | Protrusio acetabuli (HP:0003179) | 3.10913248 |
| 30 | Abnormality of complement system (HP:0005339) | 3.09663500 |
| 31 | Epidermoid cyst (HP:0200040) | 3.09472248 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.00850773 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.00850773 |
| 34 | Hyperglycemia (HP:0003074) | 2.97042968 |
| 35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.94590585 |
| 36 | Joint hemorrhage (HP:0005261) | 2.94221686 |
| 37 | Abnormality of purine metabolism (HP:0004352) | 2.86135933 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 2.80935076 |
| 39 | Purpura (HP:0000979) | 2.79258932 |
| 40 | Skin nodule (HP:0200036) | 2.75066156 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.74998064 |
| 42 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.72414806 |
| 43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.72414806 |
| 44 | Abnormality of glycolipid metabolism (HP:0010969) | 2.72414806 |
| 45 | Gingival bleeding (HP:0000225) | 2.72185952 |
| 46 | Orchitis (HP:0100796) | 2.71584880 |
| 47 | Premature rupture of membranes (HP:0001788) | 2.69428263 |
| 48 | Spontaneous abortion (HP:0005268) | 2.67893420 |
| 49 | Mitral stenosis (HP:0001718) | 2.67777064 |
| 50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.66873860 |
| 51 | Mucopolysacchariduria (HP:0008155) | 2.66873860 |
| 52 | Fat malabsorption (HP:0002630) | 2.65050946 |
| 53 | Myocardial infarction (HP:0001658) | 2.64860636 |
| 54 | Osteomalacia (HP:0002749) | 2.61855028 |
| 55 | Hypercholesterolemia (HP:0003124) | 2.59258192 |
| 56 | Gout (HP:0001997) | 2.56015151 |
| 57 | Optic neuritis (HP:0100653) | 2.53455552 |
| 58 | Retrobulbar optic neuritis (HP:0100654) | 2.53455552 |
| 59 | Systemic lupus erythematosus (HP:0002725) | 2.53137942 |
| 60 | Turricephaly (HP:0000262) | 2.52449075 |
| 61 | Abnormality of methionine metabolism (HP:0010901) | 2.51020125 |
| 62 | Cervical subluxation (HP:0003308) | 2.49862727 |
| 63 | Aortic aneurysm (HP:0004942) | 2.46815893 |
| 64 | Abnormality of nucleobase metabolism (HP:0010932) | 2.45326895 |
| 65 | Vacuolated lymphocytes (HP:0001922) | 2.45020064 |
| 66 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.44522278 |
| 67 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.44522278 |
| 68 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.44522278 |
| 69 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.43217562 |
| 70 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.39571891 |
| 71 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.39571891 |
| 72 | Cardiovascular calcification (HP:0011915) | 2.35894417 |
| 73 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.35478916 |
| 74 | Hydroxyprolinuria (HP:0003080) | 2.31882082 |
| 75 | Abnormality of proline metabolism (HP:0010907) | 2.31882082 |
| 76 | Biconcave vertebral bodies (HP:0004586) | 2.30420352 |
| 77 | Hemorrhage of the eye (HP:0011885) | 2.29927985 |
| 78 | Striae distensae (HP:0001065) | 2.27560073 |
| 79 | Cerebral aneurysm (HP:0004944) | 2.26984509 |
| 80 | Peritonitis (HP:0002586) | 2.26621202 |
| 81 | Vascular tortuosity (HP:0004948) | 2.26144001 |
| 82 | Soft skin (HP:0000977) | 2.25383949 |
| 83 | Amyloidosis (HP:0011034) | 2.21543179 |
| 84 | Vascular calcification (HP:0004934) | 2.20334333 |
| 85 | Myositis (HP:0100614) | 2.18033864 |
| 86 | Ectopia lentis (HP:0001083) | 2.17879456 |
| 87 | Hyperbilirubinemia (HP:0002904) | 2.16738186 |
| 88 | Enlarged kidneys (HP:0000105) | 2.16667581 |
| 89 | Neurofibrillary tangles (HP:0002185) | 2.16212643 |
| 90 | Retinal atrophy (HP:0001105) | 2.15970911 |
| 91 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.14130181 |
| 92 | Protuberant abdomen (HP:0001538) | 2.05868522 |
| 93 | Broad metatarsal (HP:0001783) | 2.05289533 |
| 94 | Spontaneous hematomas (HP:0007420) | 2.04256039 |
| 95 | Pulmonary embolism (HP:0002204) | 2.01303968 |
| 96 | Tetraparesis (HP:0002273) | 2.00544680 |
| 97 | Irritability (HP:0000737) | 2.00523128 |
| 98 | Hepatocellular carcinoma (HP:0001402) | 1.96775990 |
| 99 | Glomerulonephritis (HP:0000099) | 1.96229206 |
| 100 | Insulin resistance (HP:0000855) | 1.95499001 |
| 101 | Thrombophlebitis (HP:0004418) | 1.94970306 |
| 102 | Menorrhagia (HP:0000132) | 1.93846515 |
| 103 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.92634092 |
| 104 | Keratoconjunctivitis sicca (HP:0001097) | 1.91304879 |
| 105 | Sensorimotor neuropathy (HP:0007141) | 1.90472349 |
| 106 | Arterial tortuosity (HP:0005116) | 1.88827835 |
| 107 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.88679625 |
| 108 | Nephritis (HP:0000123) | 1.87749218 |
| 109 | Follicular hyperkeratosis (HP:0007502) | 1.87579815 |
| 110 | Metabolic acidosis (HP:0001942) | 1.85320472 |
| 111 | Generalized aminoaciduria (HP:0002909) | 1.84840161 |
| 112 | Dysostosis multiplex (HP:0000943) | 1.82814555 |
| 113 | Hematochezia (HP:0002573) | 1.82522581 |
| 114 | Blue sclerae (HP:0000592) | 1.81204685 |
| 115 | Atrophic scars (HP:0001075) | 1.80393608 |
| 116 | Infantile muscular hypotonia (HP:0008947) | 1.80379787 |
| 117 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.79509122 |
| 118 | Gangrene (HP:0100758) | 1.79284962 |
| 119 | Aortic dissection (HP:0002647) | 1.78905791 |
| 120 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.78739560 |
| 121 | Dicarboxylic aciduria (HP:0003215) | 1.78739560 |
| 122 | Epistaxis (HP:0000421) | 1.77233557 |
| 123 | Delayed CNS myelination (HP:0002188) | 1.77183475 |
| 124 | Beaking of vertebral bodies (HP:0004568) | 1.76576479 |
| 125 | Pseudobulbar signs (HP:0002200) | 1.75991967 |
| 126 | Keratoconjunctivitis (HP:0001096) | 1.75037147 |
| 127 | Abnormality of serum amino acid levels (HP:0003112) | 1.74526454 |
| 128 | Rickets (HP:0002748) | 1.73859386 |
| 129 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73803423 |
| 130 | Cerebral inclusion bodies (HP:0100314) | 1.71347206 |
| 131 | Abnormality of macrophages (HP:0004311) | 1.70101422 |
| 132 | Pancreatitis (HP:0001733) | 1.69169851 |
| 133 | Esophageal varix (HP:0002040) | 1.68861633 |
| 134 | Aplasia of the phalanges of the hand (HP:0009802) | 1.68798690 |
| 135 | Aplasia involving bones of the extremities (HP:0009825) | 1.68798690 |
| 136 | Joint stiffness (HP:0001387) | 1.68638093 |
| 137 | Recurrent abscess formation (HP:0002722) | 1.67402624 |
| 138 | Vertebral compression fractures (HP:0002953) | 1.66562713 |
| 139 | Aneurysm (HP:0002617) | 1.65729072 |
| 140 | Abnormal delivery (HP:0001787) | 1.64745386 |
| 141 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.64694662 |
| 142 | Mesangial abnormality (HP:0001966) | 1.63253181 |
| 143 | Chondrocalcinosis (HP:0000934) | 1.62927959 |
| 144 | Gingivitis (HP:0000230) | 1.62770641 |
| 145 | Steatorrhea (HP:0002570) | 1.62508810 |
| 146 | Ovoid vertebral bodies (HP:0003300) | 1.61636589 |
| 147 | Arthropathy (HP:0003040) | 1.58946836 |
| 148 | Asymmetric septal hypertrophy (HP:0001670) | 1.57394937 |
| 149 | Abnormality of Sharpey fibers (HP:0100685) | 1.56797268 |
| 150 | Loss of speech (HP:0002371) | 1.56389132 |
| 151 | Conjunctival telangiectasia (HP:0000524) | 1.55818553 |
| 152 | Autoimmune thrombocytopenia (HP:0001973) | 1.55230002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK1 | 5.69129098 |
| 2 | ERN1 | 4.46590618 |
| 3 | INSRR | 4.31141245 |
| 4 | BLK | 4.07953623 |
| 5 | NTRK2 | 3.95886488 |
| 6 | TRIB3 | 3.90326722 |
| 7 | BCKDK | 2.80559436 |
| 8 | MAPK15 | 2.61379116 |
| 9 | FGFR4 | 2.38008941 |
| 10 | PIK3CG | 2.25100853 |
| 11 | PRKD3 | 2.13710393 |
| 12 | CAMK1D | 2.07060770 |
| 13 | PTK6 | 1.98064289 |
| 14 | KIT | 1.96388101 |
| 15 | RIPK1 | 1.89012606 |
| 16 | FRK | 1.88171865 |
| 17 | CAMK1G | 1.79767814 |
| 18 | EPHB1 | 1.79134479 |
| 19 | EPHA3 | 1.73617311 |
| 20 | STK3 | 1.68315659 |
| 21 | AKT3 | 1.63849340 |
| 22 | MAP4K1 | 1.62380942 |
| 23 | TAOK3 | 1.60400797 |
| 24 | IRAK3 | 1.58122634 |
| 25 | PKN2 | 1.56736914 |
| 26 | GRK7 | 1.55473980 |
| 27 | WNK3 | 1.54886214 |
| 28 | PDGFRA | 1.47545247 |
| 29 | ACVR1B | 1.47460982 |
| 30 | PDK2 | 1.40184495 |
| 31 | ADRBK2 | 1.34196861 |
| 32 | LMTK2 | 1.27796768 |
| 33 | MYLK | 1.27370161 |
| 34 | WNK4 | 1.26603690 |
| 35 | PTK2 | 1.25849812 |
| 36 | TBK1 | 1.25691599 |
| 37 | MAP3K3 | 1.24682070 |
| 38 | IKBKE | 1.22707765 |
| 39 | MAP3K6 | 1.18334887 |
| 40 | MST1R | 1.16804017 |
| 41 | CCNB1 | 1.12425539 |
| 42 | RIPK4 | 1.11202619 |
| 43 | GRK1 | 1.09188668 |
| 44 | MET | 1.07921768 |
| 45 | JAK3 | 1.06180465 |
| 46 | MAP3K14 | 1.00851555 |
| 47 | FLT3 | 0.97370292 |
| 48 | MATK | 0.97327782 |
| 49 | ERBB4 | 0.97003304 |
| 50 | ZAP70 | 0.96560940 |
| 51 | PRKAA2 | 0.95972692 |
| 52 | JAK1 | 0.95701234 |
| 53 | NTRK1 | 0.94353362 |
| 54 | PIK3CA | 0.93734193 |
| 55 | CHUK | 0.93014737 |
| 56 | PAK3 | 0.92707987 |
| 57 | FGR | 0.91967342 |
| 58 | DDR2 | 0.90825759 |
| 59 | MAPKAPK3 | 0.90500475 |
| 60 | RET | 0.90166311 |
| 61 | ERBB2 | 0.86568024 |
| 62 | PDK4 | 0.85903752 |
| 63 | PDK3 | 0.85903752 |
| 64 | MAP3K7 | 0.85570133 |
| 65 | BMX | 0.84128906 |
| 66 | MAPK12 | 0.83253574 |
| 67 | LATS1 | 0.81722966 |
| 68 | HIPK2 | 0.81163358 |
| 69 | DAPK2 | 0.80454970 |
| 70 | ABL2 | 0.80235176 |
| 71 | MAP3K2 | 0.79444549 |
| 72 | MAP2K4 | 0.76637968 |
| 73 | FGFR1 | 0.75790056 |
| 74 | MAPK11 | 0.75110189 |
| 75 | MAPK7 | 0.74829352 |
| 76 | IGF1R | 0.74299960 |
| 77 | MAP2K2 | 0.73955817 |
| 78 | FER | 0.73475954 |
| 79 | NLK | 0.72806804 |
| 80 | PHKG2 | 0.72645479 |
| 81 | PHKG1 | 0.72645479 |
| 82 | SGK3 | 0.70746977 |
| 83 | JAK2 | 0.66999994 |
| 84 | IKBKB | 0.64364671 |
| 85 | NEK9 | 0.64244036 |
| 86 | ABL1 | 0.63945390 |
| 87 | CSK | 0.63664307 |
| 88 | FGFR3 | 0.61582762 |
| 89 | PDGFRB | 0.60853308 |
| 90 | CDC42BPA | 0.60155397 |
| 91 | MTOR | 0.60055762 |
| 92 | SGK2 | 0.58432717 |
| 93 | PRKCH | 0.56416019 |
| 94 | LYN | 0.56362365 |
| 95 | IRAK1 | 0.53454619 |
| 96 | IRAK4 | 0.53438748 |
| 97 | MAP3K1 | 0.52590713 |
| 98 | TRPM7 | 0.51686456 |
| 99 | MAP2K1 | 0.51335614 |
| 100 | STK38L | 0.50690148 |
| 101 | PRKAA1 | 0.50049103 |
| 102 | BMPR2 | 0.48455028 |
| 103 | PRKCG | 0.48170554 |
| 104 | LATS2 | 0.47857829 |
| 105 | GSK3A | 0.47792201 |
| 106 | PRKD1 | 0.46651136 |
| 107 | SRC | 0.46534097 |
| 108 | MAPK4 | 0.45915694 |
| 109 | MARK2 | 0.45242762 |
| 110 | TYK2 | 0.45126700 |
| 111 | PINK1 | 0.45104911 |
| 112 | DYRK1B | 0.45077393 |
| 113 | TGFBR2 | 0.44641606 |
| 114 | PRKACG | 0.44061971 |
| 115 | INSR | 0.43907414 |
| 116 | TIE1 | 0.43727281 |
| 117 | CAMKK2 | 0.43462016 |
| 118 | SGK223 | 0.43191945 |
| 119 | SGK494 | 0.43191945 |
| 120 | RPS6KA2 | 0.43186011 |
| 121 | EGFR | 0.42166332 |
| 122 | MAP2K3 | 0.41567836 |
| 123 | ADRBK1 | 0.41554072 |
| 124 | PRKCE | 0.40325194 |
| 125 | PRKG1 | 0.39545332 |
| 126 | PTK2B | 0.39048816 |
| 127 | EEF2K | 0.38948112 |
| 128 | CAMK2G | 0.38940970 |
| 129 | HCK | 0.38845508 |
| 130 | CSF1R | 0.38621164 |
| 131 | EPHA4 | 0.38348996 |
| 132 | FGFR2 | 0.37753799 |
| 133 | MUSK | 0.37069753 |
| 134 | SYK | 0.36435610 |
| 135 | CAMKK1 | 0.36157558 |
| 136 | ROCK1 | 0.35927662 |
| 137 | STK38 | 0.35655215 |
| 138 | KDR | 0.35362088 |
| 139 | EPHB2 | 0.34775502 |
| 140 | MELK | 0.34713399 |
| 141 | PAK2 | 0.33614593 |
| 142 | PDPK1 | 0.33082320 |
| 143 | LRRK2 | 0.33069699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.39283026 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.26402508 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.84160587 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.82657727 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.74240808 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.70841523 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.54714826 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.41127606 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.41031818 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.40763271 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.39350266 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.30227074 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.18871549 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.08428375 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.07351162 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.03524207 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.92303770 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.85866668 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84703402 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.84585101 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.72226958 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.68790817 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.66694190 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.60290533 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.57479110 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.52735268 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.49398812 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42962790 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.37972375 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.34575695 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.28742990 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28636164 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.28611508 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25400740 |
| 35 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.24585413 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.23989786 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.20261240 |
| 38 | Galactose metabolism_Homo sapiens_hsa00052 | 1.17946659 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15990918 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15033801 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.14502147 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13280457 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.11989459 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.11849550 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.10087431 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08346955 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.07766182 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05943996 |
| 49 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.04863114 |
| 50 | Retinol metabolism_Homo sapiens_hsa00830 | 1.02738149 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97267980 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.93608548 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92699087 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92136827 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88877643 |
| 56 | Protein export_Homo sapiens_hsa03060 | 0.85800559 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83843631 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.80770233 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.79873447 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.77942548 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77197700 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76476751 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75317913 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72514709 |
| 65 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.71569313 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.70879985 |
| 67 | Olfactory transduction_Homo sapiens_hsa04740 | 0.70658130 |
| 68 | Leishmaniasis_Homo sapiens_hsa05140 | 0.69936855 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69418605 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67506830 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67094673 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65566987 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65464884 |
| 74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65315455 |
| 75 | Tuberculosis_Homo sapiens_hsa05152 | 0.64456423 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64383947 |
| 77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64101438 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.63178279 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.62716701 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61641402 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61477308 |
| 82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60427559 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.60258926 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59505827 |
| 85 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59291972 |
| 86 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.58630897 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57202162 |
| 88 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56368370 |
| 89 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.55391778 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52955400 |
| 91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.51462279 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50735026 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50607820 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.49582326 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48666242 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45356076 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43180810 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.40894282 |
| 99 | Lysosome_Homo sapiens_hsa04142 | 0.39770136 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38123043 |
| 101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.36957986 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.36898864 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36805252 |
| 104 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35983580 |
| 105 | Asthma_Homo sapiens_hsa05310 | 0.34578059 |
| 106 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34495515 |
| 107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34074905 |
| 108 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.33470076 |
| 109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.33365973 |
| 110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32334982 |
| 111 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.32205409 |
| 112 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.31749697 |
| 113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30749702 |
| 114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.30695448 |
| 115 | Focal adhesion_Homo sapiens_hsa04510 | 0.30217893 |
| 116 | Legionellosis_Homo sapiens_hsa05134 | 0.29880184 |
| 117 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29572226 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29420784 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29022472 |
| 120 | Allograft rejection_Homo sapiens_hsa05330 | 0.28962864 |
| 121 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.28827011 |
| 122 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.28507626 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28401576 |
| 124 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.28371790 |
| 125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.27941547 |
| 126 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.25014843 |
| 127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23850802 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23257670 |
| 129 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.23136962 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21432964 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21278176 |
| 132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.19466163 |
| 133 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.19432916 |
| 134 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.17100154 |
| 135 | Amoebiasis_Homo sapiens_hsa05146 | 0.15884882 |
| 136 | Cocaine addiction_Homo sapiens_hsa05030 | 0.14909118 |
| 137 | Malaria_Homo sapiens_hsa05144 | 0.14428686 |
| 138 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.13111193 |
| 139 | Mineral absorption_Homo sapiens_hsa04978 | 0.12360297 |
| 140 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.09781124 |

